Oct 2026· Angewandte Chemie· 0 citations· 27 references
Medicine
TL;DR
A masked extracellular phase-separation platform (Condenstim) is engineered enabling tumor microenvironment-specific condensate formation and establishes a generalizable strategy to control extracellular LLPS for both fundamental studies and therapeutic applications.
Abstract
Liquid-liquid phase separation (LLPS) drives the formation of biomolecular condensates, which are fundamental to cell signaling. Extracellular phase separation is emerging as a potent strategy for cell-specific signaling modulation; however, its application is limited by the lack of control over on-demand condensate formation. Here, we engineered a masked extracellular phase-separation platform (Condenstim) enabling tumor microenvironment-specific condensate formation. To achieve this, we first developed an LLPS-based system that clusters CD3 and CD28 receptors to assemble synthetic immunological synapses for potent T-cell activation. By employing a protease-cleavable linker for site-specific PEGylation, we sterically shielded the protein building blocks, rendering the platform biologically dormant during systemic circulation. Within the tumor microenvironment, localized proteases cleave the linker, thereby restoring LLPS in situ. This modular design ensures spatially confined and efficient T-cell activation, leading to robust tumor regression in murine models, both as a monotherapy and in combination with PD-1 blockade. Our findings establish a generalizable strategy to control extracellular LLPS for both fundamental studies and therapeutic applications.
Lysosome-targeting chimeras (LYTACs) have attracted much attention due to their ability to specifically target and degrade disease-related proteins on the cell membrane. However, their clinical application is limited by poor tumor specificity, systemic off-target effects, and a lack of temporal regulation. Engineered b...
Shan Sun, Ruo-Xi Hu, Xue Zhai et al.· Journal of Controlled Releas...· 0 citations
Liquid-liquid phase separation (LLPS) is a physicochemical process through which biomolecules assemble into membraneless condensates via weak, multivalent interactions. LLPS has emerged as a central biological principle that helps explain intracellular spatiotemporal compartmentalization, signal transduction, and str...
Chen-Cheng Dong, Cong Shang, Bing-Ran Han et al.· Molecular Cancer· 0 citations
D-STAR establishes a dual-state adaptive RNA delivery framework that decouples systemic stability from activation potency, thereby offering a generalizable strategy for context-responsive precision RNA therapeutics.
Yuan-Shuai Song, Tian Jiang, Xin Shen et al.· ACS Applied Materials and In...· 0 citations
Engineering artificial dendritic cells (DCs) holds great promise for cancer immunotherapy, but achieving spatiotemporally controlled multifunctionality within the immunosuppressive tumor microenvironment remains a challenge. Here, we report a chemically engineered, ultrasound (US)-activatable artificial DCs nanosystem...
Cell-free protein synthesis (CFPS) has emerged as a versatile platform for producing proteins in vitro with exceptional programmability, rapid prototyping capability, and an open biochemical environment. However, conventional CFPS is typically performed in homogeneous solutions that lack the spatial organization, molec...
Yan-Peng Xi, Lei Liu, Meng-Yue Zhu et al.· Chemistry· 0 citations
The limited precision of controlled drug release remains a major challenge for precision cancer therapy. Herein, a protein and nucleic acid dual-biomarker-responsive CRISPR AND logic nanodevice, termed LogiCas, is developed by integrating APE1 and miRNA-21 as dual inputs for precise tumor therapy. Leveraging the string...
Jing-Ge Zhang, Yu-He Yang, Yong-Hua Wu et al.· Journal of Controlled Releas...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.